Astex, The Wellcome Trust, The Institute of Cancer Research & CRT announce major cancer alliance
Astex Technology, the fragment-based drug discovery company, together with The Wellcome Trust, the Institute of Cancer Research and Cancer Research Technology today announced an exclusive collaboration relating to the discovery of novel drugs against the cancer target BRAF.